Table 1. The Determination of the Risk for Lower BMDa According to the Presence of Pheochromocytoma.
Patients with pheochromocytoma | ||
---|---|---|
Odds ratio (95% CI) | P value | |
Lower BMD at any siteb | 2.54 (0.98–6.60) | 0.056 |
Lower BMD at the lumbar spine | 3.31 (1.23–8.56)c | 0.014c |
Lower BMD at the femur neck | 1.18 (0.31–4.45) | 0.806 |
Lower BMD at the total hip | 0.80 (0.17–3.75) | 0.772 |
Adapted from Kim et al., with permission from Oxford University Press [32].
BMD, bone mineral density; CI, confidence interval.
aLower BMD was defined by Z-score ≤−2.0 for premenopausal women and men aged <50 years, or T-score ≤−1.0 for postmenopausal women and men aged ≥50 years; b“Any site” includes the lumbar spine, femur neck, and/or total hip; cNumbers indicate statistically significant values. The multiple logistic regression analyses were performed after adjustment for age, sex, menopausal status, body mass index, current smoking, alcohol intake, regular outdoor exercise, diabetes, and medication use including corticosteroids, antihypertensive agents, bisphosphonates, and hormone replacement.